Tag: report

Vascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indications London Roots Analysis has announced the addition of “Vascular Disrupting Agents Market,... Read More

Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue sarcomas; as a result, a number of viable biological targets have been... Read More

Driven by the potential to confer sustained therapeutic effects and thereby facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon... Read More

Over time, important advances in diagnosis and the development of versatile treatment options have translated into tangible improvements in the overall survival of lung cancer patients; several targeted therapies are... Read More

Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing proprietary product candidates into the clinic Roots Analysis has announced... Read More

To request for Customize Report – https://www.rootsanalysis.com/reports/304/request-sample.html Key Inclusions  A detailed review of the current status of the market with respect to oligonucleotide manufacturers focused on research and diagnostic, and therapeutic applications.... Read More

A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of... Read More

The recent approval of Aduhelm™, an amyloid beta-directed antibody has led to players seeking approval for similar therapies; various interventions are being evaluated for the treatment / management of the... Read More

Polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the... Read More

Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings. The report features an extensive study of the current market landscape, offering an... Read More